Arbutus Biopharma Corpora...
(ABUS)
undefined
undefined%
At close: undefined
3.44
4.85%
After-hours Jan 06, 2025, 04:37 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Net Income | -72.85M | -69.46M | -76.25M | -63.74M | -153.72M | -57.10M | -84.40M | -384.16M | -61.12M | -38.84M | -14.06M | 29.95M | -9.73M | -12.41M | -9.33M | -11.72M | -2.58M | 18.08M | -8.06M | -28.05M | -34.08M | -26.79M | -14.02M | -9.20M | -8.17M | -8.75M |
| Depreciation & Amortization | 1.40M | 1.43M | 1.75M | 1.98M | 2.03M | 2.18M | 2.03M | 1.09M | 589.00K | 529.00K | 612.84K | 869.54K | 955.45K | 1.04M | 1.91M | 1.11M | 411.65K | 599.77K | 2.40M | 1.20M | 6.80M | 5.59M | 3.85M | 1.26M | 1.30M | 989.78K |
| Stock-Based Compensation | 9.30M | 7.18M | 6.42M | 6.16M | 6.80M | 6.24M | 15.12M | 39.16M | 22.09M | 3.28M | 903.00K | 986.76K | 613.24K | 650.51K | 253.73K | n/a | 380.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -18.23M | 24.48M | 517.00K | -1.13M | -42.00K | -2.74M | 3.42M | -1.07M | -13.09M | 13.34M | 77.46K | -294.65K | 2,179.40B | -498.09B | 1.80M | 2.65M | -209.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | -5.56M | -3.75M | 7.79M | 9.33M | 88.78M | -10.66M | 39.83M | 391.56M | 14.47M | 10.38M | 3.53M | 47.24K | -10.26M | 650.51K | 253.73K | -560.97K | 244.18K | -20.75M | -5.82M | 15.23M | 2.27M | 216.29K | 388.57K | -513.84K | 11.94K | n/a |
| Deferred Income Tax | n/a | n/a | -8.18M | -5.59M | -12.66M | -4.28M | -24.32M | -105.06M | -16.18M | -4.30M | -18.12K | 3.87M | 9.79M | -643.33K | 103.18K | n/a | 423.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -18.23M | 29.24M | 930.00K | 431.00K | -2.23M | -4.28M | 3.15M | -467.00K | -14.63M | 16.52M | 2.30M | -2.45M | 1.11M | -529.32K | 1.56M | 2.68M | -1.60M | -552.78K | -3.09M | 1.64M | -1.96M | 2.84M | -228.32K | 106.07K | 20.04K | 55.19K |
| Operating Cash Flow | -85.94M | -35.36M | -67.53M | -51.44M | -71.01M | -67.90M | -48.60M | -57.88M | -54.78M | -12.42M | -6.74M | 33.27M | -7.52M | -11.25M | -5.24M | -8.48M | -2.72M | -2.62M | -14.57M | -9.98M | -26.96M | -18.16M | -10.00M | -8.35M | -6.84M | -7.71M |
| Capital Expenditures | -1.01M | -512.00K | -809.00K | -229.00K | -589.00K | -1.14M | -7.26M | -4.00M | -2.29M | -1.06M | -725.10K | -14.90K | -58.45K | -830.82K | -1.62M | -966.44K | -1.36M | -94.87K | -45.01K | -7.15M | -787.73K | -1.95M | -941.64K | -203.64K | -300.63K | -3.22M |
| Acquisitions | n/a | 458.00K | 1.81M | -2.50M | 11.00K | 25.00K | 3.00K | 25.00K | 324.00K | n/a | n/a | n/a | n/a | n/a | n/a | 2.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -80.51M | -130.43M | -82.22M | -85.58M | -58.76M | -3.01M | n/a | -95.15M | n/a | -41.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.01M | -13.00M | -2.69M | n/a |
| Sales Maturities Of Investments | 132.27M | 56.00M | 70.35M | 73.40M | 87.67M | n/a | 35.09M | n/a | 9.64M | n/a | n/a | n/a | n/a | n/a | 5.47M | 2.14M | n/a | n/a | n/a | 3.94M | 17.81M | n/a | n/a | n/a | n/a | 10.26M |
| Other Investing Acitivies | 20.00K | -458.00K | -1.81M | -12.18M | 28.93M | -2.96M | 35.06M | 25.00K | 9.64M | 80.00K | -725.10B | 2.50K | -59.67B | n/a | 0.00 | n/a | 1.23K | 14.15K | 424.87K | -995.19K | -0.00 | 4.90M | 97.08K | -0.00 | 2.65K | 96.47K |
| Investing Cash Flow | 50.77M | -74.94M | -12.68M | -14.91M | 28.34M | -4.10M | 27.80M | -99.12M | 7.68M | -42.96M | -725.10K | -12.40K | -58.45K | -830.82K | 3.85M | 3.25M | -1.36M | -80.72K | 379.86K | -4.21M | 17.02M | 2.95M | -1.85M | -13.20M | -2.99M | 7.14M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -12.00M | n/a | 12.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -62.19K | -97.84K | -99.55K | -1.20M | -49.59K | 470.08K | -158.46K | -95.52K | -38.53K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | -12.14M | -12.12M | -11.15M | -10.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 795.00K | 11.49M | 14.71M | 12.57M | 30.00M | 77.74M | 49.32M | 637.00K | 1.69M | 4.20M | 678.46K | 703.00K | 10.79K | n/a | n/a | 24.75K | 5.23M | -2.78M | n/a | 247.53K | n/a | 9.70M | 5.15M | -0.16 | n/a | n/a |
| Financial Cash Flow | 30.65M | 31.81M | 137.24M | 86.75M | 37.46M | 55.60M | 49.30M | 12.64M | 143.87M | 60.68M | 32.72M | 4.57M | 4.46M | 34.91K | 7.53K | 8.15M | 20.29M | -2.87M | -1.20M | 829.10K | 20.60M | 9.79M | 35.56M | 13.07M | 19.89M | 48.90K |
| Net Cash Flow | -4.49M | -78.51M | 57.03M | 20.45M | -5.14M | -17.40M | 30.90M | -143.37M | 94.59M | 3.47M | 21.69M | 37.80M | -3.10M | -12.05M | -1.74M | 4.35M | 15.40M | -5.58M | -15.39M | -13.36M | 10.66M | -5.42M | 23.71M | -8.49M | 10.06M | -524.39K |
| Free Cash Flow | -86.94M | -35.87M | -68.34M | -51.67M | -71.59M | -69.04M | -55.86M | -61.88M | -57.07M | -13.48M | -7.46M | 33.26M | -7.58M | -12.08M | -6.86M | -9.45M | -4.08M | -2.72M | -14.62M | -17.13M | -27.75M | -20.11M | -10.95M | -8.56M | -7.14M | -10.93M |